Exploring Clinical Study Experiences of People With Anorexia Nervosa
An Analysis of Participation Trends: Observing Patient Engagement in Anorexia Nervosa Clinical Trials
1 other identifier
observational
500
1 country
1
Brief Summary
The study seeks to delve into the firsthand experiences of patients diagnosed with anorexia nervosa who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. By joining this clinical trial, individuals have the unique opportunity to contribute to the betterment of future anorexia nervosa patients and play an active role in advancing medical research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 5, 2024
CompletedFirst Posted
Study publicly available on registry
January 17, 2024
CompletedStudy Start
First participant enrolled
February 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
ExpectedJanuary 17, 2024
January 1, 2024
1 year
January 5, 2024
January 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of patients who decide to participate in anorexia nervosa clinical trial
3 months
Rate of patients who remain in anorexia nervosa clinical trial to trial completion
12 months
Eligibility Criteria
People with anorexia nervosa who are actively considering enrolling in an observational clinical trial, but have not yet completed enrollment and randomization.
You may qualify if:
- Patient has self-identified as planning to enroll in a clinical trial
- Patient has been diagnosed with anorexia nervosa
- Patient is a minimum of 18 years or older
You may not qualify if:
- Patient does not understand, sign, and return consent form
- Inability to perform regular electronic reporting
- Patient is pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Power Life Sciences
San Francisco, California, 94107, United States
Related Publications (3)
Walsh BT, Hagan KE, Lockwood C. A systematic review comparing atypical anorexia nervosa and anorexia nervosa. Int J Eat Disord. 2023 Apr;56(4):798-820. doi: 10.1002/eat.23856. Epub 2022 Dec 12.
PMID: 36508318BACKGROUNDPaolacci S, Kiani AK, Manara E, Beccari T, Ceccarini MR, Stuppia L, Chiurazzi P, Dalla Ragione L, Bertelli M. Genetic contributions to the etiology of anorexia nervosa: New perspectives in molecular diagnosis and treatment. Mol Genet Genomic Med. 2020 Jul;8(7):e1244. doi: 10.1002/mgg3.1244. Epub 2020 May 5.
PMID: 32368866BACKGROUNDParpia R, Spettigue W, Norris ML. Approach to anorexia nervosa and atypical anorexia nervosa in adolescents. Can Fam Physician. 2023 Jun;69(6):387-391. doi: 10.46747/cfp.6906387.
PMID: 37315981BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Michael B Gill
Power Life Sciences Inc.
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 5, 2024
First Posted
January 17, 2024
Study Start
February 1, 2025
Primary Completion
February 1, 2026
Study Completion (Estimated)
February 1, 2027
Last Updated
January 17, 2024
Record last verified: 2024-01